Compare AHCO & EOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AHCO | EOS |
|---|---|---|
| Founded | 2012 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.2B |
| IPO Year | N/A | N/A |
| Metric | AHCO | EOS |
|---|---|---|
| Price | $10.51 | $23.25 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $13.60 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 84.1K |
| Earning Date | 02-24-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 6.80% |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.55 | N/A |
| Revenue | ★ $3,255,213,000.00 | N/A |
| Revenue This Year | $1.07 | N/A |
| Revenue Next Year | $6.49 | N/A |
| P/E Ratio | $18.41 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.11 | $15.62 |
| 52 Week High | $11.63 | $20.63 |
| Indicator | AHCO | EOS |
|---|---|---|
| Relative Strength Index (RSI) | 59.96 | 55.51 |
| Support Level | $9.53 | $23.08 |
| Resistance Level | $10.38 | $23.62 |
| Average True Range (ATR) | 0.32 | 0.26 |
| MACD | -0.03 | 0.05 |
| Stochastic Oscillator | 82.03 | 73.65 |
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. It focuses on providing; sleep therapy equipment, supplies, and related services (including CPAP and bi-PAP services) to individuals suffering from obstructive sleep apnea (OSA), medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors (CGM and insulin pumps), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs.
Eaton Vance Enhanced Equity Income Fund II is a diversified, closed-end management investment company. The fund's primary investment objective is to provide current income, with a secondary objective of capital appreciation. Under normal market conditions, the Fund invests at least 80% of its total assets in common stocks. It invests in a portfolio of large and mid-cap securities in sectors such as Information Technology, Consumer Discretionary, Communication Services, Healthcare, Industrials, Consumer Staples, Financials, Materials, and Energy.